|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 7/04 | |
| A61P 7/00 | |||
| A61P 33/06 | |||
| A61P 29/00 | |||
| C12N 9/64 | |||
| C07K 14/755 | |||
| A61K 38/37 | |||
| A61K 38/36 | |||
| A61K 38/00 |
| (11) | Number of the document | 3392271 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18175765.9 |
| Date of filing the European patent application | 2011-07-08 | |
| (97) | Date of publication of the European application | 2018-10-24 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 36263510 P | 2010-07-08 | US |
| (72) |
Grillberger, Leopold, AT
Reiter, Manfred, AT
Fleischanderl, Daniel, AT
Bramberger, Gregor, AT
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | METHOD OF PRODUCING RECOMBINANT ADAMTS13 IN CELL CULTURE |
| METHOD OF PRODUCING RECOMBINANT ADAMTS13 IN CELL CULTURE |